Underwriter rewrites pharma guide; Pfizer sells in Brooklyn;

> Best's Underwriting & Loss Control Center, prompted by recent lawsuits and recalls, has revised its report on pharma manufacturing to help underwriters identify insurance exposures. Announcement

> Pfizer has sold eight of 13 acres at its South Williamsburg complex in Brooklyn to Acumen Capital Partners for development. Article

> Canada shed more than 3,600 pharma jobs in the second half of 2010. Article

> Production-related jobs in Russia's pharma and energy sectors are showing a 15 to 20 percent salary rise over a year ago. Article

> Nigerian officials are using TruScan handheld Raman spectrometers in Ilorin, Kwara State, in a crackdown on counterfeit malaria drugs. Story

> Thermo Fisher Scientific has unveiled the TruScan RM handheld analyzer, a faster and smaller version of the TruScan analyzer, for raw materials identification and finished product inspection. Release

> Paralympic gold medalist Jim Armstrong has been fined $30,000 for selling counterfeit Viagra and Cialis pills following a Customs and Border Protection sting at his local Mail Boxes International store in Blaine, WA. Story

> United Therapeutics plans to expand in Research Triangle Park, NC, tripling its work force for manufacturing, packaging, labeling and warehousing. Item

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.